INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 203 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $510,000 | +53.6% | 102,300 | +120.8% | 0.03% | +23.1% |
Q3 2021 | $332,000 | -50.8% | 46,326 | -36.3% | 0.03% | -58.1% |
Q1 2021 | $675,000 | +99.1% | 72,714 | -11.5% | 0.06% | +67.6% |
Q4 2017 | $339,000 | -66.5% | 82,124 | -53.1% | 0.04% | -57.5% |
Q3 2015 | $1,012,000 | – | 175,224 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Defender Capital, LLC. | 581,100 | $2,324,000 | 2.21% |
Round Table Services, LLC | 339,391 | $1,358,000 | 0.52% |
ARK Investment Management | 1,885,641 | $7,543,000 | 0.31% |
WASATCH ADVISORS LP | 5,337,930 | $21,352,000 | 0.28% |
Cedar Brook Financial Partners, LLC | 41,500 | $166,000 | 0.10% |
Unified Trust Company, N.A. | 13,716 | $54,000 | 0.05% |
Virtus ETF Advisers LLC | 60,398 | $242,000 | 0.04% |
OXFORD ASSET MANAGEMENT LLP | 394,703 | $1,579,000 | 0.04% |
FOX RUN MANAGEMENT, L.L.C. | 14,465 | $58,000 | 0.03% |
BREWIN DOLPHIN LTD | 59,123 | $236,492 | 0.03% |